Company News-Bio-Thera Solutions, Ltd.

2026-02-13

• European Commission grants approval for Gotenfia®, a golimumab biosimilar to Simponi® that was developed by Bio-Thera ...

查看详情

10-252023

Bio-Thera Solutions Announces GMP Approval from ANVISA

GUANGZHOU,China, October 24, 2023 -- Bio-Thera Solutions, Ltd (688177:SH), acommercial-stage biopharmaceutical company d...
10-082023

FDA Approves TOFIDENCE® (tocilizumab-bavi) a Biosimilar of ACTEMRA® developed by Bio-Thera Solutions

TOFIDENCE is Bio-Thera’s first productapproved by USFDA.TOFIDENCE is the first monoclonal antibodydrug researched, devel...
08-132023

Bio-Thera Solutions Announces Positive Phase 1 Clinical Data for BAT8006 (Folate-Receptor-α-ADC) and Presents Phase 1 Dose Escalation Study at the Bethune Obstetrics and Gynecology Forum

GUANGZHOU,China --(PR Newswire) -- Bio-Thera Solutions, Ltd (688177:SH), a commercial-stage biopharmaceuticalcompany dev...